Normal view MARC view ISBD view

On the rational formulation of alternative fuels: melting point and net heat of combustion predictions for fuel compounds using machine learning methods. [electronic resource]

By:

Saldana, D A

Contributor(s):

Producer: 20131213Description: 259-77 p. digitalISSN:

1029-046X

Subject(s):

Online resources:

Available from publisher's website

In: SAR and QSAR in environmental research vol. 24

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

4781 CUDC-101, a multitargeted inhibitor of histone deacetylase, epidermal growth factor receptor, and human epidermal growth factor receptor 2, exerts potent anticancer activity.
by Lai, Cheng-Jung
4782 Placentation in the African elephant, Loxodonta africanus: III. Ultrastructural and functional features of the placenta.
by Wooding, F B P
4783 ERK1/2 associates with the c-Met-binding domain of growth factor receptor-bound protein 2 (Grb2)-associated binder-1 (Gab1): role in ERK1/2 and early growth response factor-1 (Egr-1) nuclear accumulation.
by Osawa, Masaki
4784 Activation of the hepatocyte growth factor (HGF)-Met system in papillary thyroid cancer: biological effects of HGF in thyroid cancer cells depend on Met expression levels.
by Mineo, Rossana
4785 Identification of genes that modulate sensitivity of U373MG glioblastoma cells to cis-platinum.
by Ma, Yongxian
4786 Correlation of Epstein-Barr virus and its encoded proteins with Helicobacter pylori and expression of c-met and c-myc in gastric carcinoma.
by Luo, Bing
4787 Involvement of hepatocyte growth factor in branching morphogenesis of murine salivary gland.
by Ikari, Tatsuya
4788 Identification of pyrrolo[2,1-f][1,2,4]triazine-based inhibitors of Met kinase.
by Schroeder, Gretchen M
4789 Human bone marrow-derived stem cell proliferation is inhibited by hepatocyte growth factor via increasing the cell cycle inhibitors p53, p21 and p27.
by Chen, Ketian
4790 Sox11 expression in astrocytic gliomas: correlation with nestin/c-Met/IDH1-R132H expression phenotypes, p-Stat-3 and survival.
by Korkolopoulou, P
4791 qPCR in gastrointestinal stromal tumors: Evaluation of reference genes and expression analysis of KIT and the alternative receptor tyrosine kinases FLT3, CSF1-R, PDGFRB, MET and AXL.
by Fassunke, Jana
4792 Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancer.
by Suda, Kenichi
4793 Genes associated with autism spectrum disorder.
by Li, Xiaohong
4794 Phenotypic drug screening and target validation for improved personalized therapy reveal the complexity of phenotype-genotype correlations in clear cell renal cell carcinoma.
by Schneider, Meike
4795 MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
by Luraghi, Paolo
4796 Gene mutations in small-cell lung cancer (SCLC): results of a panel of 6 genes in a cohort of Italian patients.
by Bordi, Paola
4797 Discrepancies between FISH and immunohistochemistry for assessment of the ALK status are associated with ALK 'borderline'-positive rearrangements or a high copy number: a potential major issue for anti-ALK therapeutic strategies.
by Ilie, M I
4798 Reconstructing targetable pathways in lung cancer by integrating diverse omics data.
by Balbin, O Alejandro
4799 Evidence that depletion of the sorting nexin 1 by siRNA promotes HGF-induced MET endocytosis and MET phosphorylation in a gefitinib-resistant human lung cancer cell line.
by Nishimura, Yukio
4800 Triple inhibition of EGFR, Met, and VEGF suppresses regrowth of HGF-triggered, erlotinib-resistant lung cancer harboring an EGFR mutation.
by Nakade, Junya